Home › Funds › Parkwood LLC › GLUE

Parkwood LLC position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

Parkwood LLC reported holding 505,000 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$12.2M, representing 0.87% of its reported portfolio and ranking #44 among its reported holdings. Parkwood LLC has disclosed GLUE holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)505.00K sh
Reported value held$12.22M
Portfolio Weight0.87%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Parkwood LLC's GLUE position evolved

Parkwood LLC first disclosed a stake in GLUE in Q3 2024 at 426,620 shares (US$2.3M). The position peaked in Q2 2026 at 505,000 shares, worth US$12.2M. Across 8 filings, Parkwood LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 505,000 shares valued at US$12.2M. Notable position changes include a 119% increase in Q1 2025 (shares fell 3% over the following quarter), a 29% trim in Q1 2026 (shares rose 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 426.62K $2.26M New
Q4 2024 323.00K $2.24M Reduce
Q1 2025 708.00K $3.29M Add
Q2 2025 708.00K $3.19M Hold
Q3 2025 708.00K $5.25M Hold
Q4 2025 708.00K $11.10M Hold
Q1 2026 505.00K $8.31M Reduce
Q2 2026 505.00K $12.22M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has Parkwood LLC held GLUE?

Parkwood LLC has disclosed GLUE holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Parkwood LLC's current position in GLUE?

As of Q2 2026, Parkwood LLC holds 505.00K shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $12.22M, representing 0.87% of its reported portfolio and ranking #44.

Has Parkwood LLC been buying or selling GLUE?

In the latest 13F filing (Q2 2026), Parkwood LLC held unchanged its position in GLUE. The position peaked in Q2 2026 at 505.00K shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.